| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
Evaluating the rate of reversal of fentanyl-induced respiratory depression using a novel long-acting naloxone nanoparticle, cNLX-NP.
Evaluating the rate of reversal of fentanyl-induced respiratory depression using a novel long-acting naloxone nanoparticle, cNLX-NP.
Averick SE, Kassick AJ, Song D, Zhang B, Vigliaturo J, Luengas D, Silva-Ortiz P, Pravetoni M, Raleigh MD.
Front Psychiatry. 2024 Mar 14;15:1366186. doi: 10.3389/fpsyt.2024.1366186. PMID: 38550534; PMCID: PMC10973107.